We are live on ! Find out more

1,726 hedge funds and large institutions have $120B invested in Merck in 2015 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 692 increasing their positions, 690 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more first-time investments, than exits

New positions opened: 105 | Existing positions closed: 72

7% more funds holding in top 10

Funds holding in top 10: 128137 (+9)

1% more funds holding

Funds holding: 1,7121,726 (+14)

0.35% more ownership

Funds ownership: 74.26%74.61% (+0.35%)

0% more repeat investments, than reductions

Existing positions increased: 692 | Existing positions reduced: 690

1% less capital invested

Capital invested by funds: $121B → $120B (-$1.21B)

5% less call options, than puts

Call options by funds: $936M | Put options by funds: $990M

Holders
1,726
Holders Change
+14
Holders Change %
+0.82%
% of All Funds
46.27%
Holding in Top 10
137
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+7.03%
% of All Funds
3.67%
New
105
Increased
692
Reduced
690
Closed
72
Calls
$936M
Puts
$990M
Net Calls
-$54.4M
Net Calls Change
-$276M

MRK Hedge Fund Activity: Q2 2015 in Review

1,726 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2015, worth a combined $120B — down 1% from $121B a quarter earlier.

Buyers outnumbered sellers: 105 funds opened new MRK positions and 72 closed out — a net gain of 33 holders — while 692 added to existing stakes and 690 trimmed.

The largest buyer was Sanders Capital, opening a new position worth an estimated $527M. The largest seller was Capital World Investors, cutting an estimated $692M.

  • 1,726 institutional investors held Merck (MRK) as of Q2 2015, up from 1,712 in Q1 2015.
  • Funds reported $120B of Merck stock for Q2 2015, down 1% quarter-over-quarter.
  • 105 funds opened new Merck positions in Q2 2015 and 72 closed out, a net change of +33 holders.
  • The largest Merck buyer in Q2 2015 was Sanders Capital, an estimated $527M added.
  • The largest Merck seller in Q2 2015 was Capital World Investors, an estimated $692M sold.

Based on aggregated 13F filings for Q2 2015.